Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. Girard TD, Exline MC, Carson SS, Hough CL, Rock P, Gong MN, Douglas IS, Malhotra A, Owens RL, Feinstein DJ, Khan B, Pisani MA, Hyzy RC, Schmidt GA, Schweickert WD, Hite RD, Bowton DL, Masica AL, Thompson JL, Chandrasekhar R, Pun BT, Strength C, Boehm LM, Jackson JC, Pandharipande PP, Brummel NE, Hughes CG, Patel MB, Stollings JL, Bernard GR, Dittus RS, Ely EW, MIND-USA Investigators (2018) N Engl J Med 379: 2506-2516 Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P (2001) Mol Psychiatry 6: 293-301 The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Konradi C, Kobierski LA, Nguyen TV, Heckers S, Hyman SE (1993) Proc Natl Acad Sci U S A 90: 7005-9 Neurotensin-deficient mice show altered responses to antipsychotic drugs. Dobner PR, Fadel J, Deitemeyer N, Carraway RE, Deutch AY (2001) Proc Natl Acad Sci U S A 98: 8048-53 Heat shock protein 12A shows reduced expression in the prefrontal cortex of subjects with schizophrenia. Pongrac JL, Middleton FA, Peng L, Lewis DA, Levitt P, Mirnics K (2004) Biol Psychiatry 56: 943-50 Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Konradi C, Heckers S (2001) Biol Psychiatry 50: 729-42 Dopamine depletion of the prefrontal cortex induces dendritic spine loss: reversal by atypical antipsychotic drug treatment. Wang HD, Deutch AY (2008) Neuropsychopharmacology 33: 1276-86 Occupancy of striatal and extrastriatal dopamine D2/D3 receptors by olanzapine and haloperidol. Kessler RM, Ansari MS, Riccardi P, Li R, Jayathilake K, Dawant B, Meltzer HY (2005) Neuropsychopharmacology 30: 2283-9 Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat. Wang HD, Dunnavant FD, Jarman T, Deutch AY (2004) Neuropsychopharmacology 29: 1230-8 Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. Albaugh VL, Vary TC, Ilkayeva O, Wenner BR, Maresca KP, Joyal JL, Breazeale S, Elich TD, Lang CH, Lynch CJ (2012) Schizophr Bull 38: 153-66 Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P (2002) J Neurosci 22: 2718-29 Intracellular modulation of NMDA receptor function by antipsychotic drugs. Leveque JC, Macías W, Rajadhyaksha A, Carlson RR, Barczak A, Kang S, Li XM, Coyle JT, Huganir RL, Heckers S, Konradi C (2000) J Neurosci 20: 4011-20 Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. Fadel J, Bubser M, Deutch AY (2002) J Neurosci 22: 6742-6 mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission. Dadalko OI, Siuta M, Poe A, Erreger K, Matthies HJ, Niswender K, Galli A (2015) J Neurosci 35: 8843-54 Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler EJ (1995) J Neurosci 15: 2453-61 Conserved chromosome 2q31 conformations are associated with transcriptional regulation of GAD1 GABA synthesis enzyme and altered in prefrontal cortex of subjects with schizophrenia. Bharadwaj R, Jiang Y, Mao W, Jakovcevski M, Dincer A, Krueger W, Garbett K, Whittle C, Tushir JS, Liu J, Sequeira A, Vawter MP, Gardner PD, Casaccia P, Rasmussen T, Bunney WE, Mirnics K, Futai K, Akbarian S (2013) J Neurosci 33: 11839-51 Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata. Bradley SR, Marino MJ, Wittmann M, Rouse ST, Awad H, Levey AI, Conn PJ (2000) J Neurosci 20: 3085-94 Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA (2003) J Neurosci 23: 6315-26 The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study. Bourdelais AJ, Deutch AY (1994) Cereb Cortex 4: 69-77 Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, Pun BT, Thompson JL, Shintani AK, Meltzer HY, Bernard GR, Dittus RS, Ely EW, MIND Trial Investigators (2010) Crit Care Med 38: 428-37 Discovery, synthesis, and structure-activity relationship development of a series of N-4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4 (mGlu(4)) with oral efficacy in an antiparkinsonian animal model. Jones CK, Engers DW, Thompson AD, Field JR, Blobaum AL, Lindsley SR, Zhou Y, Gogliotti RD, Jadhav S, Zamorano R, Bogenpohl J, Smith Y, Morrison R, Daniels JS, Weaver CD, Conn PJ, Lindsley CW, Niswender CM, Hopkins CR (2011) J Med Chem 54: 7639-47 Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM). Morris LC, Nance KD, Gentry PR, Days EL, Weaver CD, Niswender CM, Thompson AD, Jones CK, Locuson CW, Morrison RD, Daniels JS, Niswender KD, Lindsley CW (2014) J Med Chem 57: 10192-7 Effects of typical and atypical antipsychotics on human glycine transporters. Williams JB, Mallorga PJ, Conn PJ, Pettibone DJ, Sur C (2004) Schizophr Res 71: 103-12 A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Woodward ND, Purdon SE, Meltzer HY, Zald DH (2007) Schizophr Res 89: 211-24 Effect of psychotropic drug treatment on sterol metabolism. Korade Ž, Liu W, Warren EB, Armstrong K, Porter NA, Konradi C (2017) Schizophr Res 187: 74-81 Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist. Iderberg H, Maslava N, Thompson AD, Bubser M, Niswender CM, Hopkins CR, Lindsley CW, Conn PJ, Jones CK, Cenci MA (2015) Neuropharmacology 95: 121-9 The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease. Johnson KA, Jones CK, Tantawy MN, Bubser M, Marvanova M, Ansari MS, Baldwin RM, Conn PJ, Niswender CM (2013) Neuropharmacology 66: 187-95 Haloperidol-induced alteration in the physiological actions of group I mGlus in the subthalamic nucleus and the substantia nigra pars reticulata. Marino MJ, Awad-Granko H, Ciombor KJ, Conn PJ (2002) Neuropharmacology 43: 147-59 Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation. Young CD, Bubser M, Meltzer HY, Deutch AY (1999) Psychopharmacology (Berl) 144: 255-63 Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. Li J, Guo Y, Schroeder FA, Youngs RM, Schmidt TW, Ferris C, Konradi C, Akbarian S (2004) J Neurochem 90: 1117-31 Stoichiometry of tyrosine hydroxylase phosphorylation in the nigrostriatal and mesolimbic systems in vivo: effects of acute haloperidol and related compounds. Salvatore MF, Garcia-Espana A, Goldstein M, Deutch AY, Haycock JW (2000) J Neurochem 75: 225-32 The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease. Jones CK, Bubser M, Thompson AD, Dickerson JW, Turle-Lorenzo N, Amalric M, Blobaum AL, Bridges TM, Morrison RD, Jadhav S, Engers DW, Italiano K, Bode J, Daniels JS, Lindsley CW, Hopkins CR, Conn PJ, Niswender CM (2012) J Pharmacol Exp Ther 340: 404-21 Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation. Ahmed MR, Gurevich VV, Dalby KN, Benovic JL, Gurevich EV (2008) J Pharmacol Exp Ther 325: 276-83 Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function. Matthews RT, McMillen BA, Sallis R, Blair D (1986) J Pharmacol Exp Ther 239: 124-31 Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata. Wittmann M, Marino MJ, Conn PJ (2002) J Pharmacol Exp Ther 302: 433-41 Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum. Bubser M, Deutch AY (2002) Eur J Neurosci 15: 713-20 Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein. Konradi C, Heckers S (1995) Neuroscience 65: 1051-61 Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Deutch AY, Cameron DS (1992) Neuroscience 46: 49-56 Antipsychotic drugs induce Fos protein in the thalamic paraventricular nucleus: a novel locus of antipsychotic drug action. Deutch AY, Ongür D, Duman RS (1995) Neuroscience 66: 337-46 The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Deutch AY, Duman RS (1996) Neuroscience 70: 377-89
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.